Aker BioMarine warns omega-3 demand could outstrip fish oil supply next year
Aker BioMarine warns that traditional global omega-3 supplies are reaching a tipping point. The krill and algae oil supplier links these to limitations in traditional crude fish oil supplies and growing demand for omegas from consumers and industries, ranging from aquaculture to pet nutrition. In the first installment of our two-part series on the omega-3 market, Nutrition Insight meets with Ross Norris, general manager for Asia-Pacific at Aker BioMarine, who says that dependence on the Peruvian anchovy fisheries exposes the sector to supply shocks and price spikes.Consumer interest is building, but solutions are still relatively underdeveloped. What’s driving the shift – and why could enzymes be part of what comes next? Explore the trends, science and untapped potential around histamine intolerance in our latest guide.
Technical paper brought to you by Bioiberica.
GLP-1 has driven interest in metabolic health, said Phynova’s VP EMEA, Alexis Manfré. He presented a technology that measures the body’s “metabolic memory” via advanced glycation end-products, while showcasing that Reducose can help manage blood sugar and insulin spikes after meals. Manfré sees consumers becoming more specific about choosing products that help them manage blood glucose levels, through which they can also manage their metabolic health. He also discussed how one clinical study shows that a serving of Reducose had an immediate effect on natural GLP-1 secretion by a “triple-digit percent.”
Settings
- Play Interval
- Slide Duration
- Thumbnail Bar Position

Latest headlines

GLP-1 companion ingredients Oct 2026
Multimedia
GLP-1 has driven interest in metabolic health, said Phynova’s VP EMEA, Alexis Manfré. He presented a technology that measures the body’s “metabolic memory” via advanced glycation end-products, while showcasing that Reducose can help manage blood sugar and insulin spikes after meals. Manfré sees...




































